What’s in a name? Coining history’s deadliest pandemics

Here’s some scientific nomenclature to help kick-start your Monday! For centuries before the advent of coronavirus, many contagions, including the Bubonic Plague, syphilis, smallpox and tuberculosis, claimed the lives of hundreds of millions of people worldwide. Ironically, many of these contagions were awarded a ‘rainbow’ of names. Syphilis – a bacterial infection commonly spread by…

Read More

The rise of telehealth

For a long time, access to healthcare has been an ongoing struggle for many rural and remote communities around Australia, with many facing long wait times, limited access to specialist services, and the need to travel long distances to major cities. Furthermore, office-workers and parents with young children often have difficulty finding time to attend…

Read More

Aussies & Kiwis with incurable blood cancer receive newly subsidised treatment option

Today, VIVA! partnered with Celgene, a Bristol-Myers Squibb company, Multiple Myeloma Australia and Multiple Myeloma New Zealand to announce a newly reimbursed treatment option for Australians and New Zealanders living with incurable blood cancer, multiple myeloma. REVLIMID® (lenalidomide) – the first and only maintenance treatment in ANZ specifically indicated and reimbursed for those with newly…

Read More

Sleep-deprived Aussies at risk of Alzheimer’s

This World Sleep Day, VIVA! partnered with GenesisCare outlining new research that linked just one night’s lost sleep to increased risk of Alzheimer’s Disease. This research highlights the urgent need for Australian’s to improve their sleep hygiene. The research, recently published in Neurology Journal, reinforces the strong link between lack of sleep and increased levels…

Read More